8 results match your criteria: "Rambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute[Affiliation]"
J Clin Endocrinol Metab
June 2019
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Purpose: African Americans who shed JC polyomavirus (JCV) in their urine have reduced rates of nondiabetic chronic kidney disease (CKD). We assessed the associations between urinary JCV and urine BK polyomavirus (BKV) with CKD in African Americans with diabetes mellitus.
Methods: African Americans with diabetic kidney disease (DKD) and controls lacking nephropathy from the Family Investigation of Nephropathy and Diabetes Consortium (FIND) and African American-Diabetes Heart Study (AA-DHS) had urine tested for JCV and BKV using quantitative PCR.
Clin Microbiol Infect
March 2017
Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva and Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Israel.
J Exp Med
July 2016
Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
The analysis of individuals with telomere defects may shed light on the delicate interplay of factors controlling genome stability, premature aging, and cancer. We herein describe two Coats plus patients with telomere and genomic defects; both harbor distinct, novel mutations in STN1, a member of the human CTC1-STN1-TEN1 (CST) complex, thus linking this gene for the first time to a human telomeropathy. We characterized the patients' phenotype, recapitulated it in a zebrafish model and rescued cellular and clinical aspects by the ectopic expression of wild-type STN1 or by thalidomide treatment.
View Article and Find Full Text PDFBreast Cancer Res
June 2015
Diabetes and Metabolism Clinical Research Center of Excellence, Clinical Research Institute at Rambam (CRIR) and the Faculty of Medicine, Technion, Rambam Medical Center, P.O.B 9602, Haifa, 31096, Israel.
Introduction: Breast tumors are comprised of distinct cancer cell populations which differ in their tumorigenic and metastatic capacity. Characterization of cell surface markers enables investigators to distinguish between cancer stem cells and their counterparts. CD24 is a well-known cell surface marker for mammary epithelial cells isolation, recently it was suggested as a potential prognostic marker in a wide variety of malignancies.
View Article and Find Full Text PDFClin Exp Dermatol
August 2015
Department of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Endocr Relat Cancer
April 2015
Clinical Research Institute at Rambam (CRIR) and the Faculty of MedicineTechnion, Diabetes and Metabolism Clinical Research Center of Excellence, Haifa, IsraelThe Laboratory of Molecular MedicineRambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute, Technion, Haifa 31096, IsraelDivision of EndocrinologyDiabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York, USA Clinical Research Institute at Rambam (CRIR) and the Faculty of MedicineTechnion, Diabetes and Metabolism Clinical Research Center of Excellence, Haifa, IsraelThe Laboratory of Molecular MedicineRambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute, Technion, Haifa 31096, IsraelDivision of EndocrinologyDiabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York, USA
Accumulating evidence from clinical trials indicates that specific targeting of the IGF1 receptor (IGF1R) is not efficient as an anti-breast cancer treatment. One possible reason is that the mitogenic signals from the insulin receptor (IR) can be processed independently or as compensation to inhibition of the IGF1R. In this study, we highlight the role of the IR in mediating breast tumor progression in both WT mice and a hyperinsulinemic MKR mouse model by induction of Ir (Insr) or Igf1r knockdown (KD) in the mammary carcinoma Mvt-1 cell line.
View Article and Find Full Text PDFHum Mol Genet
July 2014
Laboratory of Molecular Medicine, Rambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute, Technion, Haifa 31096, Israel,
Human telomeric regions are packaged as constitutive heterochromatin, characterized by extensive subtelomeric DNA methylation and specific histone modifications. ICF (immunodeficiency, centromeric instability, facial anomalies) type I patients carry mutations in DNA methyltransferase 3B (DNMT3B) that methylates de novo repetitive sequences during early embryonic development. ICF type I patient fibroblasts display hypomethylated subtelomeres, abnormally short telomeres and premature senescence.
View Article and Find Full Text PDFFront Oncol
March 2013
Rambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute, Molecular Medicine Laboratory, Technion-Israel Institute of Technology Haifa, Israel.
Mutations in the human DNA methyltransferase 3B (DNMT3B) gene lead to ICF (immunodeficiency, centromeric region instability, and facial anomalies) syndrome type I. We have previously described a telomere-related phenotype in cells from these patients, involving severe hypomethylation of subtelomeric regions, abnormally short telomeres and high levels of telomeric-repeat-containing RNA (TERRA). Here we demonstrate that ICF-patient fibroblasts carry abnormally short telomeres at a low population doubling (PD) and enter senescence prematurely.
View Article and Find Full Text PDF